Nexome Capital Markets Ltd
Incorporated in 2000, Nexome Capital Markets Ltd is engaged mainly in merchant banking and trading in government securities and shares.[1]
- Market Cap ₹ 91.7 Cr.
- Current Price ₹ 85.4
- High / Low ₹ 138 / 67.2
- Stock P/E 7.67
- Book Value ₹ 177
- Dividend Yield 1.75 %
- ROCE 10.4 %
- ROE 7.46 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.47 times its book value
- Company is expected to give good quarter
- Company has delivered good profit growth of 181% CAGR over last 5 years
Cons
- The company has delivered a poor sales growth of -6.50% over past five years.
- Company has a low return on equity of 3.13% over last 3 years.
- Earnings include an other income of Rs.4.99 Cr.
- Debtor days have increased from 24.5 to 70.8 days.
- Working capital days have increased from 25.4 days to 74.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | 40 | 46 | 53 | 49 | 49 | 71 | 70 | 57 | 237 | 43 | 51 | 32 | |
| Sales growth | +24% | +17% | +15% | +16% | -8% | +0% | +45% | -1% | -18% | +314% | -82% | +17% | -25% |
| 33 | 39 | 45 | 52 | 48 | 48 | 70 | 69 | 57 | 236 | 41 | 32 | 19 | |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 19 | 12 |
| OPM % | 3.8% | 3.5% | 2.8% | 2.7% | 2.6% | 1.4% | 1.8% | 1.0% | 1.4% | 0.4% | 5% | 38% | 39% |
| 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 3 | 0 | -2 | 5 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Profit before tax | 1 | 1 | 1 | 1 | 1 | 0 | 3 | 2 | 1 | 3 | 2 | 15 | 14 |
| Tax % | 4% | 22% | 11% | -222% | 27% | 53% | 91% | 3% | 30% | 27% | 43% | 28% | |
| 1 | 1 | 1 | 2 | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 11 | 11 | |
| EPS in Rs | 1.43 | 1.42 | 1.22 | 4.13 | 0.78 | 0.12 | 0.47 | 3.37 | 0.85 | 4.02 | 1.86 | 12.15 | 11.06 |
| Dividend Payout % | 65% | 49% | 77% | 23% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -7% |
| 3 Years: | -4% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 181% |
| 3 Years: | 188% |
| TTM: | 323% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 18% |
| 3 Years: | 24% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 9 | 11 |
| Reserves | 99 | 99 | 100 | 105 | 104 | 96 | 98 | 110 | 112 | 123 | 148 | 163 | 179 |
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 6 | |
| 2 | 2 | 1 | 1 | 1 | 2 | 2 | 7 | 3 | 3 | 6 | 4 | 7 | |
| Total Liabilities | 107 | 106 | 106 | 112 | 110 | 104 | 106 | 123 | 120 | 132 | 163 | 183 | 203 |
| 8 | 8 | 8 | 7 | 7 | 6 | 5 | 4 | 3 | 2 | 5 | 10 | 8 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 10 | 19 | 34 | 35 | 30 | 21 | 73 | 81 | 82 | 91 | 116 | 123 | 157 |
| 88 | 79 | 65 | 70 | 74 | 76 | 29 | 38 | 35 | 39 | 41 | 50 | 37 | |
| Total Assets | 107 | 106 | 106 | 112 | 110 | 104 | 106 | 123 | 120 | 132 | 163 | 183 | 203 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | 7 | 17 | -19 | -9 | -3 | 45 | -4 | -7 | -5 | -3 | 10 | |
| 2 | -7 | -3 | 5 | 9 | 3 | -45 | 8 | 3 | 6 | -6 | -27 | |
| -1 | -1 | -0 | -0 | -1 | -0 | -0 | -0 | -0 | 0 | 8 | 22 | |
| Net Cash Flow | 1 | -1 | 14 | -14 | -1 | -0 | 1 | 4 | -4 | 1 | -1 | 6 |
| Free Cash Flow | -1 | 7 | 17 | -19 | -9 | -3 | 49 | -1 | -7 | -1 | -5 | 8 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -14% | 497% | 1,354% | -1,253% | -647% | -370% | 3,526% | -517% | -841% | -482% | -85% | 80% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 36 | 7 | 1 | 0 | 1 | 1 | 2 | 1 | 0 | 2 | 71 |
| Inventory Days | 130 | 37 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payable | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 25 | 0 | 0 | 0 | |
| Cash Conversion Cycle | 156 | 73 | 8 | 1 | 1 | 1 | -1 | -22 | 1 | 0 | 3 | 71 |
| Working Capital Days | 167 | 71 | 282 | 354 | 16 | 9 | 6 | -4 | 24 | 0 | 2 | 75 |
| ROCE % | 1% | 1% | 1% | 1% | 1% | 0% | 1% | 0% | 1% | 1% | 1% | 10% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Market Operations share of total revenue % ・Standalone data |
|
|||||||||||
| Investment Banking Operations share of total revenue % ・Standalone data |
||||||||||||
| Investment portfolio value ₹ Lakhs |
||||||||||||
| Number of permanent employees employees ・Standalone data |
||||||||||||
| BSE Sensex year-end level index points ・Standalone data |
||||||||||||
| Demat accounts in India millions ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement - Unaudited Financial Results for the quarter ended September 30, 2026
-
Outcome Of Board Meeting Dated November 06 2026
- Board approved Q2 FY2026-27 results on November 6, 2026; reviewed rights issue utilization and deviation statement.
-
Integrated Financials For The Quarter Ended 30.09.2026
- Nexome Capital filed Q2 FY27 results; standalone PAT Rs212.86 lakh, consolidated PAT Rs207.26 lakh, no rights-issue deviation.
-
Statement Of Deviation & Variation For The Quarter Ended September 30, 2026
- No deviation in rights issue fund utilisation for quarter ended 30 September 2026; Rs. 22.03 crore raised.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- CARE report for quarter ended 30 Sep 2026 confirms ₹22.04 crore rights issue proceeds fully utilized, with nil deviation.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) is a SEBI-registered Category I Merchant Banker providing merchant banking and corporate advisory services. The Company executes assignments in mergers & acquisitions (M&A), project advisory, debt syndication, and equity and debenture placements, supporting corporate fundraising and strategic transactions.